Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to DNA Full portfolio

Position in DNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$390,175
+$45,449 QoQ
Shares Held
39,372
-30.0% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 183 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNA Over Time

Shares Held

Position Value (USD)

Derivatives in DNA

reported options exposure · as of Jun 30, 2026
CallValue
$4,109,677
CallShares
414,700
PutValue
$1,297,219
PutShares
130,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. DNA ranks #177 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in DNA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,297,219 130,900
2026-06-30 $390,175 39,372
2026-06-30 $4,109,677 414,700
2026-03-31 $1,197,802 195,400
2026-03-31 $344,726 56,236
2026-03-31 $984,478 160,600
2025-12-31 $839,276 100,996
2025-12-31 $798,591 96,100
2025-12-31 $2,113,233 254,300
2025-09-30 $4,161,132 285,400
2025-09-30 $3,456,304 237,058
2025-09-30 $5,355,234 367,300
2025-06-30 $3,655,125 324,900
2025-06-30 $2,100,116 186,677
2025-06-30 $2,799,000 248,800
2025-03-31 $1,980,180 347,400
2025-03-31 $687,288 120,577
2025-03-31 $1,116,060 195,800
2024-12-31 $3,424,234 348,700
2024-12-31 $1,311,451 133,549
2024-12-31 $2,721,122 277,100
2024-09-30 $102,665 12,597
2024-09-30 $3,644,680 447,200
2024-09-30 $4,327,650 531,000
2024-06-30 DNABW — 69,402
2024-06-30 $428,522 1,283,000
2024-06-30 $681,654 2,040,883
2024-06-30 $107,915 323,100
2024-03-31 DNABW — 54,355
2024-03-31 $644,264 555,400
2024-03-31 $1,876,300 1,617,500
2024-03-31 $2,985,479 2,573,689
2023-12-31 DNABW — 54,355
2023-12-31 $3,256,799 1,927,100
2023-12-31 $1,132,976 670,400
2023-12-31 $8,197,650 4,850,681
2023-09-30 DNABW — 80,132
2023-09-30 $5,298,700 2,927,459
2023-09-30 $1,197,496 661,600
2023-09-30 $3,857,653 2,131,300
2023-06-30 DNABW — 54,355
2023-06-30 $1,076,754 578,900
2023-06-30 $3,741,576 2,011,600
2023-06-30 $5,341,103 2,871,561
2023-03-31 DNABW — 54,355
2023-03-31 $878,731 660,700
2023-03-31 $3,428,145 2,577,553
2023-03-31 $2,673,034 2,009,800
2022-12-31 DNABW — 54,355
2022-12-31 $1,093,261 646,900

Report a Problem

Category
Description
Email (optional, for follow-up)